Trials / Withdrawn
WithdrawnNCT03825302
Prostaglandin E2 as a Critical Mediator of Sex Disparities in Asthma
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This study seeks to understand how biological sex influences airway hyperresponsiveness in adult asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Methacholine challenge | Methacholine inhalation challenge will be administered to both male and females with asthma |
| DIAGNOSTIC_TEST | Mannitol challenge | Mannitol inhalation challenge will be administered to both male and females with asthma |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2022-12-01
- Completion
- 2022-12-01
- First posted
- 2019-01-31
- Last updated
- 2022-03-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03825302. Inclusion in this directory is not an endorsement.